DNA & Synthetic Vaccines

Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based.

 

    Related Conference of DNA & Synthetic Vaccines

    November 26-27, 2021

    33rd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada
    December 01-02, 2021

    41st Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    March 09-10, 2022

    6th International Conference on Vaccines and Immunology

    Geneva, Switzerland
    April 18-19, 2022

    Global Summit on Vaccines and Immunology

    Madrid, Spain
    October 07-08, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland

    DNA & Synthetic Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in